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Aims Duchenne muscular dystrophy (DMD) is a muscle disease with serious cardiac complications. Changes in Ca2+
homeostasis and oxidative stress were recently associated with cardiac deterioration, but the cellular pathophysio-
logical mechanisms remain elusive. We investigated whether the activity of ryanodine receptor (RyR) Ca2+ release
channels is affected, whether changes in function are cause or consequence and which post-translational modifica-
tions drive disease progression.
Methods
and results
Electrophysiological, imaging, and biochemical techniques were used to study RyRs in cardiomyocytes from mdx mice,
an animal model of DMD. Young mdx mice show no changes in cardiac performance, but do so after 8 months.
Nevertheless, myocytes from mdx pups exhibited exaggerated Ca2+ responses to mechanical stress and ‘hypersen-
sitive’ excitation–contraction coupling, hallmarks of increased RyR Ca2+ sensitivity. Both were normalized by anti-
oxidants, inhibitors of NAD(P)H oxidase and CaMKII, but not by NO synthases and PKA antagonists.
Sarcoplasmic reticulum Ca2+ load and leak were unchanged in young mdx mice. However, by the age of 4–5
months and in senescence, leak was increased and load was reduced, indicating disease progression. By this age,
all pharmacological interventions listed above normalized Ca2+ signals and corrected changes in ECC, Ca2+ load,
and leak.
Conclusion Our findings suggest that increased RyR Ca2+ sensitivity precedes and presumably drives the progression of dys-
trophic cardiomyopathy, with oxidative stress initiating its development. RyR oxidation followed by phosphorylation,
first by CaMKII and later by PKA, synergistically contributes to cardiac deterioration.
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1. Introduction
Cytoskeletal remodelling often accompanies cardiac hypertrophy and
failure.1 Dystrophinopathies represent a unique group of diseases in
which the cytoskeletal disarray is not only a consequence but also
the cause of the disease. They result from mutations in the dystrophin
gene.2 Duchenne muscular dystrophy (DMD) is among the most severe
forms of dystrophy. Cardiac manifestations of the disease are present in
the majority of adolescent boys with DMD. About 20% of the patients
suffer from ventricular dysfunctions and arrhythmias that ultimately lead
to heart failure or sudden cardiac death.3 The most commonly used
animal model of DMD is the mdx mouse, which lacks dystrophin.
Mdx mice develop dilated cardiomyopathy over an 8-month
period.4,5 By that age they also show electrocardiographic and magnetic
resonance imaging abnormalities and develop sustained ventricular
tachycardia when challenged with isoproterenol.6
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The cellular pathology of the failing heart often shows impaired
intracellular Ca2+ homeostasis, including abnormal excitation–
contraction (EC) coupling.7 It is well described that at different
stages of dystrophic cardiomyopathy its cellular phenotype exhibits
augmented intracellular Ca2+ responses (i.e. a burst of Ca2+ sparks
and waves) to mechanical stress,8 –10 hypersensitive EC-coupling,11
increased Ca2+ leak from the sarcoplasmic reticulum (SR), and
reduced SR Ca2+ load.6 These features clearly point to modifications
in intracellular Ca2+ cycling and suggest elevated activity of Ca2+-
induced Ca2+ release (CICR) from the SR via ryanodine receptor
(RyR). As underlying causes, several and probably not mutually exclu-
sive mechanisms of RyRs sensitization have been considered. They
include oxidative9 and nitrosative6 post-translational modifications
of RyRs as well as their phosphorylation by PKA.12 However, a
causal links between these modifications and alterations of RyR func-
tion, development of cellular abnormalities and progression of dys-
trophic cardiomyopathy have not yet been established clearly.
The aim of this study was to define the interactions among several
cellular pathomechanisms that converge to a common endpoint—
they ultimately all sensitize or even hypersensitize the CICR machin-
ery, in particular the RyRs. In addition, we wanted to determine
whether RyR hypersensitivity to Ca2+ precedes and therefore pos-
sibly underlies the progression of this disease. We found that gradually
developing and additive modifications of RyRs provoke the degrad-
ation of cardiomyocyte function that may ultimately result in cardiac
failure in muscular dystrophy.
2. Methods
For additional information on methods, see Supplementary material
online.
2.1. Cell isolation
All experiments conformed with the NIH Guide for the Care and Use of
Laboratory Animals published by the US National Institute of Health (NIH
publication, 8th edition, 2011) and were approved by the Institutional
Animal Care and Use Committee of the New Jersey Medical School,
USA and by the State Veterinary Office of Bern, Switzerland. C57BL10
mice (wild-type, WT) and dystrophin-deficient mdx (C57BL/
10ScSn-mdx) mice at the age of 1 (young), 3–4 (adult), and 12–15
months (senescent) were used in this study. Animals were purchased
from the Jackson Laboratory. Ventricular myocytes were enzymatically
isolated as previously described.13 Briefly, mice were heparinized
(5000 U/kg), anaesthetized with sodium pentobarbital (100 mg/kg), and
checked to ensure the absence of movement, flexor, and pedal reflexes.
Hearts were then quickly removed, mounted on a Langendorff apparatus
and perfused with a solution containing collagenase and protease. Ventri-
cles were cut into small pieces from which cells dissociated with time.
Myocytes were used for experiments within 5 h after isolation.
2.2. Cellular experiments
Changes in cytoplasmic [Ca2+] and production of reactive oxygen species
(ROS) were monitored with fluorescent indicators fluo-3 AM (5 mM) and
5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate (CM-
H2DCFD, 20 mM), respectively, and a laser-scanning confocal microscope
(Bio-Rad, Radiance 2000) in XY-scan mode at the rate of 0.5 Hz. Dyes
were excited with the 488 nm line of an Argon laser. The emitted light
was collected above 500 nm. SR Ca2+ leak was estimated as described in
Shannon et al.14 Cells were paced at 1 Hz in external control solution to
obtain steady-state levels of SR Ca2+ load, and starting from the last five
beats, [Ca2+]i was recorded in the line-scan mode (500 lines/s). After
pacing, external solution was rapidly switched to Na+ and Ca2+-free solu-
tion for 15 s to stop Ca2+ influx and to inhibit Ca2+ removal via the NCX
and thus, to avoid Ca2+ overload or Ca2+ unloading of the cells. Addition of
tetracaine (1 mM, 15 s) eliminated RyR-mediated diastolic Ca2+ leak,
leading to a rapid decrease in [Ca2+]i proportionally to the leak. The peak
of the caffeine-induced Ca2+ transient measured after tetracaine washout
(10 mM caffeine, 2 s) was used to estimate SR load. Membrane currents
were recorded using the whole-cell patch-clamp technique with an Axo-
patch 200B amplifier (Axon Instruments). Cells were voltage clamped
using low-resistance (1.5–3 MV) borosilicate glass micropipettes filled
with pipette solution which contained (in mL): 120 CsAsp, 8 NaCl, 20 tetra-
ethylammonium (TEA)-Cl, 5.5 MgCl2, 4 adenosine-triphosphate K salt,
5 HEPES, and 0.1 K5-fluo-3. pH was adjusted to 7.2 with CsOH and osmo-
larity was 305 mOsm. All experiments were carried out at room tempera-
ture, which may represent an experimental limitation of our studies.
2.3. Phosphorylation and oxidation of RyRs
Phosphorylation status of RyRs at Ser-2808 (PKA) and Ser-2814 (CaMKII)
was assessed with antibodies purchased from Badrilla (UK) and CaMKII
expression was evaluated with antibodies donated by Dr M.E. Anderson
(University of Iowa), using standard procedures.15 Briefly, mouse ventricu-
lar tissue was collected and sonicated in the radio-immunoprecipitation
assay (RIPA) lysis buffer. Forty micrograms of protein lysate per sample
were denatured in 4× sodium dodecyl sulfate polyacrylamide gel
electrophoresis sample loading buffer. Proteins were separated by elec-
trophoresis in 4% (for RyR2) and 10% (for CaMKII), respectively, SDS–
polyacrylamide gel, transferred to nitrocellulose membrane (Bio-Rad,
CA) at 15 V for 16–18 h at 48C (for RyR2) and at 90 V for 90 min at
48C (for CaMKII), blocked with 1% bovine serum albumin in tris(hydroxy-
methyl)aminomethane (TRIS)-buffered saline Tween (TBS: 20 mM
TRIS–HCl, 200 mM NaCl, 0.6% Tween 20, pH 7.5) for 1 h and probed
for proteins of interest.
The content of free thiols was determined using a monobromobimane
(mBB, Calbiochem, USA) assay.16 Isolated cardiomyocytes were permea-
bilized and incubated with 1 mM mBB for 1 h in a dark room. The proteins
were separated in 4–15% TGX SDS-gels (Bio-Rad, CA, USA) and imaged
with UV excitation (360 nm). Total RyR2 was determined from Coomas-
sie blue staining of gels run in parallel and confirmed by western blotting
with anti-RYR2 (Thermo Scientific, MA, USA) and mass spectrometry at
UMDNJ core facility.
2.4. Statistics
Results are shown as mean+ standard error (SEM). All data sets contain
results from a minimum of three mice (number on the figures indicates
the number of cells studied with imaging and electrophysiological techni-
ques or the number of tissue samples in biochemical experiments). Stat-
istical significance was evaluated by Student’s t-test. A P-value of ,0.05
was considered significant.
3. Results
3.1. RyRs are already hypersensitive to
activation by Ca21 in myocytes from
young mdx mice
At the age of 1 month, dystrophic mice do not exhibit any signs of
cardiac disease. However, 74% of apparently normal dystrophic cardi-
omyocytes exhibited exaggerated intracellular Ca2+ signals (Ca2+
waves and sparks) in response to a mechanical challenge applied as
mild hypo-osmotic shock at rest. In contrast, intracellular Ca2+ tran-
sients in WT cells were minimal and detected only in 20% of myo-
cytes (Figure 1A). Since the extent of Ca2+ influx is only slightly
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larger in mdx myocytes,9,17 this observation was taken as a strong in-
dication of increased Ca2+ sensitivity of RyRs in young dystrophic
hearts.
In order to obtain more detailed insight into RyR function, we mea-
sured Ca2+ currents (ICa), corresponding Ca
2+ transients, and deter-
mined the gain of EC coupling in patch-clamped cells. EC-gain reflects
the efficiency of signal transduction between L-type Ca2+ channels
and RyRs. The gain is calculated as the ratio of Ca2+ transient ampli-
tude to the peak of corresponding ICa. When cells were superfused
with a normal experimental solution, containing 1.8 mM Ca2+, we
found no significant difference in the amplitudes of ICa, Ca
2+ transi-
ents and values of EC-coupling gain between the two groups of
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cells within a range of test voltages (225 to +50 mV). This observa-
tion was in agreement with our previous findings in myocytes from
more mature animals.11 Then we repeated the analysis of Ca2+ tran-
sients and ICa at the lowest test voltage (225 mV), but under condi-
tions that challenge the fidelity of EC-coupling mechanisms—reduced
Ca2+ concentration in the superfusion solution (0.5 mM instead of
1.8 mM).11,18 As a result, ICa and Ca
2+ transient amplitudes were sig-
nificantly decreased in all cardiomyocytes. However, the correspond-
ing reduction in the amplitude in cytosolic Ca2+ transient was
significantly less in mdx cells compared with WT, while the amplitude
of ICa was affected to the same extent (Figure 1B, middle panes). This
corresponds to a significantly smaller reduction in EC-coupling gain in
dystrophic cells (Figure 1B, right panels). Thus, in contrast to young
WT myocytes, SR Ca2+ release in mdx cells exhibited a surprising re-
sistance to the reduction in ICa trigger, revealing a hypersensitivity in
EC-coupling that is an additional indication of an increased sensitivity
of RyRs to Ca2+.
An abnormal Ca2+ sensitivity of the RyRs could manifest itself as an
elevated SR Ca2+ leak, resulting in a decreased Ca2+ content of the
SR, reduced SR Ca2+ release, and impaired cellular contractility.
Such changes were previously observed in 3- to 4-month-old mdx
myocytes and were attributed to hyper-phosphorylation of RyRs by
PKA.19 We compared the transient Ca2+ leak from the SR with the
resting SR Ca2+ load using a method developed in Shannon et al.14
The SR of intact cardiomyocytes was loaded with Ca2+ by a
train-of-field stimulations. Subsequently, the SR Ca2+ leak was esti-
mated from the decrease in resting [Ca2+]i following the addition of
the RyR blocker tetracaine. The peak of a caffeine-induced Ca2+ tran-
sient after tetracaine washout was used to estimate the SR Ca2+ load.
No statistically significant increase in the transient SR Ca2+ leak was
observed in myocytes from young mice, suggesting that the detection
of such changes requires more severe modifications in RyRs functions
(see below). The somewhat higher SR Ca2+ content in mdx myocytes
may result from the slightly elevated trans-sarcolemmal Ca2+ influx in
these cells.9,17,20
3.2. Hypersensitivity of RyRs is driven by
oxidation in young mdx myocytes
There is a number of post-translational modifications that may con-
tribute to the increased sensitivity of RyR activation by Ca2+. Oxida-
tion, nitrosation, and phosphorylation are among them. Oxidative
modification of RyRs was one of the first proposed mechanisms con-
tributing to an impaired Ca2+ homeostasis of dystrophic cardiomyo-
cytes.9,21 Moreover, an increased activity of plasmalemmal NAD(P)H
oxidase (NOX) was identified to be a major source of oxidative stress
in dystrophic cardiomyopathy.9,10,21 Here we tested whether oxida-
tive stress modifies RyR functions already in very early stages of the
disease. Four groups of experiments were performed: we (i) com-
pared the extent of ROS production in WT and mdx cardiomyocytes
with confocal microscopy and CM-H2DCFDA; (ii) assessed the oxida-
tion and phosphorylation status of RyRs using mBB assays and
phospho-specific antibodies against RyR PKA and CaMKII sites
Ser-2808 and Ser-2814; (iii) evaluated the oxidative status of
CaMKII with antiserum against oxidized Met281/282 residues; and
(iv) tested whether scavengers of ROS, inhibitors of NOX, CaMKII,
PKA, and various isoforms of nitric oxide synthase (eNOS, nNOS
and iNOS) ‘normalize’ hypersensitive Ca2+ responses to osmotic
shock and EC-coupling in dystrophic myocytes.
To assess oxidative stress, myocytes isolated from WT and mdx
mice were identically loaded with CM-H2DCFDA. CM-H2DCFDA is
hydrolyzed to DCFH in the cell, and DCFH is oxidized to form the
highly fluorescent DCF compound in the presence of an appropriate
oxidant. It should be noted that, as many other ROS indicators, DCF
is not exclusively selective to detect ROS, but also some reactive ni-
trogen species (RNS). DCF-related fluorescence was followed for
3 min under resting conditions (Figure 2A). The slope of the aver-
aged DCF signal largely reflects the rate of cellular ROS production.
It was significantly greater in mdx cells. Another way to assess the
redox state of the cytosol is to normalize resting DCF fluorescence
(F0) to the signal after addition of 10 mM H2O2 (Fmax). The relative
increase of fluorescence after the addition of H2O2 was significantly
smaller in mdx myocytes, also indicating an increased resting ROS/
RNS level in dystrophic hearts of young animals. Purified cardiac
RyR tetramer contains multiple free cysteines22 which can be
readily oxidized. The content of free thiols in RyRs was determined
with the mBB technique. Relative content of free thiols in RyR was
70% greater in WT, suggesting that oxidative stress in dystrophic
cells resulted in oxidation of RyRs (Figure 2B).
RyRs are also predisposed to phosphorylation by both CaMKII and
PKA. Moreover, CaMKII itself is susceptible to oxidative activation.23
Figure 1 Intracellular calcium homeostasis in cardiomyocytes from 1-month-old mice. (A) Intracellular Ca2+ responses to mild hypo-osmotic shock
in WT and mdx cells. Left panels are XY images of cardiac myocytes after returning to isotonic solution and line-scan representations of series of
images acquired from the cells on the left upon application of an osmotic challenge. Averaged fluorescence was determined within each cell and con-
verted to a two-dimensional X,t image (as in Martins et al.32). Bars under the line-scans depict the protocol of extracellular solution changes. Right
panel represents pooled data of mean values of normalized fluorescence during 60 s after the osmotic shock. The averaged response to the osmotic
shock was extremely small in WT cells compared with mdx. (B) Left panels show representative traces of Ca2+ currents, line-scan images of Ca2+-
related fluorescence and normalized cytosolic transients elicited by a 400 ms test pulse to 225 mV in WT and mdx cells superfused with either 1.8 or
0.5 mM Ca2+. Line plot on the top represents the voltage protocol used for the experiments. Right panel shows the statistical comparison of
EC-coupling gain in 0.5 mM Ca2+ in WT and mdx cells. For each group, data were normalized to the value of the gain obtained in 1.8 mM Ca2+.
SR Ca2+ release was much more resistant to the reduction in ICa trigger in mdx myocytes. (C) Left panels illustrate intracellular Ca
2+ signals
during the protocol designed to estimate SR Ca2+ leak (as in Shannon et al.14): line-scan images of fluo-3 fluorescence and normalized cytosolic tran-
sients. Bars on the bottom depict the protocol of extracellular solution changes. Averaged values of estimated SR Ca2+ leak and SR Ca2+ load in WT
and mdx cells are shown at the right. The SR Ca2+ leak was determined as a reduction in the resting fluo-3 fluorescence following tetracaine appli-
cation, expressed as a per cent of SR Ca2+ content estimated from the amplitude of the caffeine-induced SR Ca2+ transient. There was no significant
difference in the values obtained in WT and mdx cells. See Supplementary material online, Table S1 for details.
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Based on our data, the enzyme is expected to be more actively
involved in mdx cardiomyocytes, as the amount of oxidized enzyme
increased about 2-fold in dystrophic cells (Figure 2C). We assessed
the phosphorylation status of RyRs with phospho-specific antibodies
against Ser-2814 (putative phosphorylation site for CaMKII) and
Ser-2808 (proposed site for PKA phosphorylation). These
experiments indicate that CaMKII-, but not PKA-mediated phosphor-
ylation, also contribute to the early cellular dysfunctions in dystrophic
cardiomyopathy (Figure 2D).
To further evaluate the contribution of each particular post-
translational RyR modification, a set of functional studies with
various pharmacological tools was carried out. Figure 2E illustrates
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that the reducing agent 2-mercaptopropionyl glycine (MPG, 1 mM),
inhibitors of NOX (apocynin, 0.5 mM and diphenylene iodonium,
10 mM) and CaMKII [K-93, 5 mM and autoctamide-2-related inhibitory
peptide (AIP), 2.5 mM] reversibly inhibited intracellular Ca2+
responses to osmotic shock and normalized EC-coupling in mdx
cells. In contrast, various PKA inhibitors (H89, 5 mM, KT5720,
2 mM, and PKA inhibitory peptide (PKI), 5 mM) as well as inhibitors
of nNOS, eNOS, and iNOS (S-methyl-L-thiocitrulline, 10 mM and
1400 W, 100 nM, respectively) had no significant effect on the intra-
cellular Ca2+ signals in mdx myocytes from young animals (see Sup-
plementary material online, Table S1 for details). Note that after
testing a broad range of inhibitors of PKA and CaMKII in the experi-
ments with osmotic shock, we used only the more specific inhibitory
peptides of kinases (AIP and PKI) in subsequent work. Right panel in
Figure 2D shows that ‘hypersensitive’ gain of EC coupling in dystrophic
cells was also normalized by reducing factors and inhibitors of NOX
and CaMKII but was not affected by inhibitors of PKA or NOS. These
results are in agreement with biochemical studies by us and others,6,19
which did not reveal changes in PKA-phosphorylation or nitrosative
status of RyRs in very young mdx hearts. Taken together, the findings
presented so far are consistent with the hypothesis that oxidative
stress due to an increased production of ROS by NOX drives the cel-
lular pathology of cardiac dystrophy at very early stages of the disease.
3.3. The progression of cellular pathology
in cardiac dystrophy
Data presented above suggest that cellular abnormalities in isolated
dystrophic cardiomyocytes clearly precede the first clinical signs of
cardiomyopathy.4,5 Here we followed up on the progression of the
cellular phenotype of the disease to the age where heart dysfunction
becomes prominent. Ventricular myocytes were isolated from
3–4- and 12–15-month-old animals. Similar to the experiments
shown above, intracellular Ca2+ responses to mild osmotic shock,
EC-coupling, SR Ca2+ leak, and load were examined. Data are sum-
marized in Figure 3, which also includes some results from
1-month-old mice adapted from Figure 1 for comparison. With the
progression of the disease, more mdx cardiomyocytes exhibited ex-
cessive intracellular Ca2+ responses to osmotic shock (74, 90, and
95% for the three age groups studied, respectively). EC coupling
became extremely hypersensitive at the age of 3–4 months ( just
before the clinical onset of the disease), but sensitivity remained rela-
tively high in the senescent animals. Contrary to cells from young
mice, the transient SR Ca2+ leak significantly increased in mdx cells
isolated from 3- to 4-month-old animals. This was associated with a
tendency towards reduced SR Ca2+ content. However, a significant
decrease in the SR Ca2+ load was only recorded in very old
animals that had already developed cardiac myopathy. This decrease
is at least partly responsible for a reduced resistance of the
EC-coupling gain to challenges when compared with younger
animals (i.e. reducing [Ca2+] in the external solution and applying a
small test depolarization, Figure 3B).
We also carried out experiments similar to those illustrated in
Figure 2. It seems that by the age of 3–4 months ( just before the ap-
pearance of clinical signs of cardiac dystrophy) several post-
translational modifications additively enhance RyR function resulting
in increased SR Ca2+ leak, reduced SR Ca2+ content, and conse-
quently impaired force production by the individual myocytes. In
cells from mdx mice older than 3 months, activation of NOS and
PKA also seems to contribute to the hypersensitivity, possibly
further aggravating the disease at later stages. A variety of pharmaco-
logical tools supports this conclusion as they not only normalized
intracellular Ca2+ responses during mechanical stress and EC coupling
in older animals (Figures 4A and B, and 5) but also significantly reduced
intracellular Ca2+ leak in senescent mice (Figure 4C).
4. Discussion
Most cardiac diseases are accompanied by substantial remodelling of
the heart tissue, also on cellular and molecular level.24 Depending
on the cause of the illness and the particular pathophysiology,
various adaptive remodelling mechanisms can initially compensate
for the functional impairments. Unfortunately, some of these initially
beneficial processes can become maladaptive with time and during
progression of the illness, finally aggravating rather than improving
the cardiac condition. This interplay between (i) defects causing a
cardiac disease and (ii) the remodelling mechanisms that try to main-
tain function leads to a very complex situation. This complexity makes
it extremely challenging to unravel the causal disease mechanisms and
to comprehend the evolution of the disease. However, such an under-
standing would greatly facilitate the development of new therapies
and the identification of new drug targets.
Figure 2 Post-translational modifications of RyRs in cells from 1-month-old mice. (A) Representative images of DCF fluorescence in WT and mdx
myocytes under resting conditions and after application of 10 mM H2O2. Graph at the bottom left illustrates changes in the averaged DCF signals. Bar
graphs compare the rate of DCF oxidation (slope) at rest and normalized increases in DCF signals after application of H2O2 in WT and mdx cells. The
values were 0.027+0.004 and 0.039+ 0.003 for the slope and 18.93+1.81 and 15.14+ 1.33 for F(max)/F0 in WT and mdx cells, respectively. Both
groups of measurements indicate higher ROS production in mdx cells. (B) Representative Coomassie-stained gel and mBB fluorescence intensity blot
in samples from WT and mdx hearts. Bar plot shows averaged data on free thiol content in RyRs from WT myocytes normalized to the corresponding
value in mdx cells. The level of free thiols is significantly greater in WT hearts. (C) Immunoblots and summary of oxidized CaMKII. Band intensities
recorded from mdx samples were normalized per GAPDH signals and expressed as a percentage of increase compared with values obtained in WT
samples. The level of oxidized CaMKII are almost two-fold higher in mdx hearts. (D) Immunoblot and summary of phosphorylated RyR. Whereas
normalized intensity of CaMKII-dependent immunoreactivity increased 3-fold in dystrophic tissue, the value did not change significantly for the
PKA site. Numbers of samples studied are indicated on the bars. (E) Reduction in oxidative stress and CaMKII inhibition suppress exaggerated intra-
cellular Ca2+ responses to osmotic shock (left panel) and prevent hypersensitivity of EC-coupling (right panel). In the experiments with osmotic
shock, individual intracellular Ca2+ responses were averaged within each experimental group (e.g. each pharmacological intervention applied) and
normalized to the averaged response under control conditions (no drug applied). In the EC-coupling gain experiments, averaged data within each
experimental group were also normalized to the values obtained in control (no drug applied) conditions. Details are in Supplementary material
online, Table S1.
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One possible strategy to gain insight into the interplay between
causal and adaptive alterations of cardiac muscle is to follow the
disease progression over longer periods of time. This approach is
based on the rationale that causal changes can presumably be identi-
fied from the beginning of the disease, even before the pathology
becomes manifest, while adaptive and maladaptive processes will
develop at later stages only.
Based on this reasoning we carried out the present study, examin-
ing disease progression in dystrophic cardiomyopathy. Because of
their slowly developing cardiac phenotype, mdx mice are a useful
model for studies of the progression of DMD that can help to identify
the cellular sequence of events leading from the genetic defect (lack
of functional dystrophin) to the onset of cardiac disease. Hearts of
1- to 2-month-old mdx mice seem to have normal morphology, left
ventricular function, and echocardiograms. First signs of cardiac
disease, such as reduced left ventricular filling, ejection fraction, and
ejection rate, are seen only in 3-month-old animals. These changes
are more prominent and can be detected earlier in the right ventricle.
By 8 months of age, hearts from mdx mice are dilated, hypertrophied,
somewhat fibrotic, and poorly contracting.4,5,25 Ventricular cardio-
myocytes isolated from senescent but not young mdx animals also
show signs of dilated cardiomyopathy. The diameter of mdx myocytes
from old animals is significantly smaller, and their length is significantly
greater than that of WT cells [in mm: 22.2+ 0.6 and 127.8+2.4 (n ¼
57) vs. 24.7+0.77 and 116.1+2.5 (n ¼ 65)], although cell capaci-
tance is not changed [in pF: 239.0+21.2 (n ¼ 32) vs. 244.5+20.6
(n ¼ 32) in mdx and WT cells, respectively]. Tropnonin I was found
to be degraded in dystrophic hearts.21 In addition, measurements in
dystrophic mdx papillary muscles revealed that the myofibrillar
Ca2+ sensitivity is reduced, a finding which contributes to the weak
force, in addition to the smaller Ca2+ transients.26 Additionally, elec-
trocardiographic (ECG) deviations such as diminished R- and S-wave
amplitudes gradually become apparent in mdx mice. By the age of
6 months shortening of the PR interval and polymorphic R-waves
suggest disturbances in the cardiac conduction system.27,28
While in the mdx mouse cardiomyopathy only becomes apparent in
adulthood, the dystrophin protein is absent throughout the lifetime of
the animal. Thus, functional consequences of the lack of dystrophin,
such as stress sensitivity, would be expected to be present even in
very young and apparently healthy mice. For our study, we focussed
on the presently prevailing hypothesis to explain the damages
caused by the lack of this protein, which links cytoskeletal proteins
with the cell environment: the ‘Ca2+ hypothesis of muscular dys-
trophy’.29 This hypothesis proposes that the membrane fragility
resulting from the lack of dystrophin leads to extra influx of Ca2+
via micro-ruptures and/or stretch activated channels, and that these
Ca2+ signals are subsequently amplified by CICR and ultimately lead
to activation of Ca2+ activated proteases, to mitochondrial damage
and apoptotic or necrotic cell death. This hypothesis has recently
been elaborated to contain another aggravating culprit, excessive oxi-
dative stress.
Our results obtained using cardiomyocytes isolated from young
animals now suggest that the oxidative stress is possibly among the
very initial problems dystrophic myocytes encounter (Figure 5). In
these cells, ROS production was already abnormally high. Further-
more, ROS scavengers and inhibitors of NAD(P)H oxidase could
prevent most of the acute Ca2+ signalling alterations, suggesting
NOX as the primary source of this oxidative stress. Why and how
Figure 3 Gradual deterioration of intracellular Ca2+ homeostasis during the development of cardiac dystrophy. Intracellular Ca2+ responses to
osmotic shock (A), gain of EC-coupling (B), intracellular Ca2+ leak (C), and SR Ca2+ content (D) in WT and mdx cardiomyocytes isolated from
1-, 3–4-, and 12–15-month-old mice. Note the gradually increased SR Ca2+ leak and decreased SR Ca2+ load in mdx cardiomyocytes from older
mice. The corresponding values are listed in Supplementary material online, Table S2.
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NOX becomes abnormally activated in dystrophic cells is not entirely
clear and several possibilities exist. For example, NOX over-
expression has been reported in dystrophic muscle.21,30Activation
of NOX could occur indirectly after Ca2+ influx, via phosphorylation
by Ca2+-sensitive PKC.31–33 PKC could also become activated via
Angiotensin II receptor signalling, which seems to be activated by
stretch, even in the absence of an agonist.34 An activation of NOX
by stretch exerted via the intracellular tubulin network has also
been suggested.10
NOX/ROS-mediated signalling has a significant downstream impact
on Ca2+-signalling proteins, and presumably on many other proteins
important for cell function. RyRs are not exquisitely susceptible to
oxidative modulation. ROS can also turn on CaMKII in a Ca2+-
independent way.23 This leads to further RyR sensitization by CaMKII-
dependent phosphorylation, as observed here with antibodies and
with pharmacological CaMKII inhibitors. Taken together, these
mechanisms explain the susceptibility of dystrophic cardiomyocytes
and their Ca2+-signalling system to stress at the very early subclinical
phases of the disease.
Our studies further suggest that later during the progression of dys-
trophic cardiomyopathy, but before heart failure is observed, nitrosa-
tion and PKA-dependent phosphorylation contribute to the increased
sensitivity of RyRs to Ca2+, in agreement with recently published
data.6,19,36 At this stage of the disease, mdx mice and DMD patients
often exhibit electrocardiographic abnormalities, such as premature
ventricular beats. Moreover, during physical or emotional stress,
CPVTs have also been reported in boys with DMDs.35 It is possible
that under these conditions additional b-adrenergic input may lead
to SERCA and ICa stimulation, followed by phosphorylation of the
RyRs, culminating in a high arrhythmogenic potential due to over-
loaded SR and hypersensitive RyRs.19
Finally, our data indicate that at the terminal stages of cardiac dys-
trophy, several post-translational modifications together hypersensitize
RyR to an extent where SR Ca2+ leak dramatically increases. This may
Figure 4 Reduction in oxidative/nitrosative stress as well as CaMKII and PKA inhibition ameliorates excessive intracellular Ca2+ responses to
osmotic shock and hypersensitivity of EC-coupling in mdx myocytes isolated from 3- to 4-month-old mice (A and B) and reduces SR Ca2+ leak in
cells from mature 12- 15-month-old mdx mice (C). In the experiments with osmotic shock (A), individual intracellular Ca2+ responses were deter-
mined as mean values of fluorescence recorded within the cell during 60 s after the shock, then averaged within each experimental group (e.g. each
pharmacological intervention applied) and normalized to the averaged response under control conditions (no drug applied). In the EC-coupling gain
experiments (B), averaged data within each experimental group were normalized to the values obtained in control (no drug applied) conditions.
(C) Typical intracellular Ca2+ signals measured during the ‘leak’ protocol and averaged values of estimated SR Ca2+ leak under control conditions
in WT and mdx cells and in mdx myocytes pretreated with various pharmacological agents (dashed bars). All values are listed in Supplementary
material online, Table S1.
Cellular phenotype of cardiac dystrophy 673
subsequently contribute to cytosolic and mitochondrial Ca2+ over-
load,9,17 activation of necrotic and apoptotic processes, and loss of func-
tional myocytes. The latter step usually precedes the development of
cardiac fibrosis and reduction in heart contractility.4 In parallel,
enhanced and uncompensated SR Ca2+ leak results in a reduction in
SR Ca2+ load, which will in turn reduce the amplitude of beat-to-beat
intracellular Ca2+ transients, thus resulting in reduced force production
by the surviving cardiomyocytes. These two cellular processes could
eventually impede cardiac contractility leading to cardiac failure.
5. Conclusions
The present study revealed the gradual time-dependent unfolding of
prominent disease pathomechanisms in dystrophic hearts. Our
major conclusion is that overall oxidative stress may be more import-
ant as one of the early steps of an initial cellular injury than previously
thought. We suggest that the ‘Ca2+ hypothesis’ of cardiac dystrophy
should be significantly modified as it was previously implemented for
skeletal muscle disease.37 Obviously, this view should also be consid-
ered when developing new therapies for muscular dystrophy. One
can speculate that therapies could even benefit from a combined ap-
proach, where oxidative stress and RyR hypersensitivity would be tar-
geted simultaneously.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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